A pharmaceutical company focused on women’s health is seeking novel druggable targets and drug candidates in the area of obstetrics and gynaecology for in-licence or early collaborative opportunities. The team is interested in new compounds and targets that will provide therapeutic benefit in the area of women’s health, such as: infertility, polycystic ovary syndrome, diminished ovarian reserve, primary ovarian insufficiency, endometriosis, adenomyosis, uterine fibroid, menopause, senium, etc.
Technology
Academic Researcher
Centre of Excellence
Research Project
Spinout Company
Biotech Asset
Technology
Academic Researcher
Centre of Excellence
Research Project
Spinout Company
Biotech Asset
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.